Browse Drug Recalls

9 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 9 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 9 FDA drug recalls.

Clear
DateProductReasonClassFirm
Aug 20, 2026 Reliable-1 Laboratories Lubricating Tears, Sterile, 0.5 FL OZ (15 mL) bottles... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 Walgreens Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Lubricant ... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 Major LubriFresh P.M. Nighttime Ointment, Net wt. 0.125 oz. (3.5 g) tubes, Di... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 Walgreens Lubricant Eye Drops, 0.5 FL OZ (15 mL) 1.0 FL OZ (30 mL) TOTAL, 2 c... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, ... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 Lubricant Eye Drops-Cameron Pharmaceuticals, Carboxymethylcellulose Sodium 0.... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye ... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye ... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC
Aug 20, 2026 TRP The Relief Products* Gentle Eyes Lubricant Eye Drops, Carboxymethylcellul... Lack of Assurance of Sterility Class II Sterling Pharmaceutical Services LLC

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.